Palladium(II)/Copper Halide/Solvent Combination for Selective Intramolecular Domino Reactions
(s), 125.3 (d), 128.1 (s), 138.1 (s), 160.5 (s); IR: n=3427,
1661 cmÀ1 MS: m/z=316 (M+); anal. calcd. for
C18H21ClN2O: C 68.24, H 6.68, N 8.84; found: C 68.21, H
6.51, N 8.73.
(400 MHz, CDCl3): d=1.10–2.97 (m, 10H), 3.31–3.41 (m,
;
1H), 3.47–3.51 (m, 1H), 3.58–3.63 (m, 1H), 3.71–3.79 (m,
1H), 3.91–4.08 (m, 1H), 4.61–4.75 (m, 1H), 7.20 (dd, J=7.1,
8.0 Hz, 1H), 7.35 (dd, J=1.1 ,7.1 Hz, 1H), 7.50 (d, J=
1.1 Hz, 1H), 7.68 (d, J=8.0 Hz, 1H), 10.00 (s br, 1H);
13C NMR (100 MHz, CDCl3): d=26.1 (t), 31.2 (t), 32.1 (t),
33.2 (t), 35.1 (d), 45.3 (t), 51.9 (d), 113.1 (d), 117.2 (s), 120.1
(d), 121.1 (d), 124.9 (s), 125.2 (d), 127.7 (s), 137.5 (s), 158.0
(s); IR: n=3441, 1668 cmÀ1; MS: m/z=361 (M+); anal.
calcd. for C18H21BrN2O: C 59.84, H 5.86, N 7.75; found: C
59.68, H 5.99, N 7.64.
4-(Chloromethyl)-2-phenyl-2,3,4,9-tetrahydropyridoACTHNUTRGNEU[GN 3,4-
b]indol-1-one (3c): Yield: 76%; eluent: hexane/AcOEt
1
65:35; yellow solid; mp 2068C (i-Pr2O). H NMR (400 MHz,
CDCl3): d=3.59–3.62 (m. 1H), 3.80 (t, J=10.7 Hz, 1H),
3.89 (dd, J=4.0, 10.7 Hz, 1H), 4.32 (dd, J=1.8, 12.8 Hz,
1H), 4.41 (dd, J=4.5, 12.8 Hz, 1H), 7.21 (dd, J=7.5, 8.0 Hz,
1H), 7.37–7.39 (m, 3H), 7.49–7.54 (m, 4H), 7.68 (d, J=
8.0 Hz, 1H), 10.63 (br s, 1H); 13C NMR (100 MHz, CDCl3):
d=35.9 (d), 44.4 (t), 53.6 (t), 113.5 (d), 118.7 (s), 120.3 (d),
121.2 (d), 124.8 (s), 125.8 (d), 126.4 (d), 127.2 (d), 127.7 (s),
129.5 (d), 138.3 (s), 142.4 (s), 160.6 (s); IR: n=3442,
General Procedure for the Arylation/Esterification
Reactions (Conditions B)
1675 cmÀ1
;
MS: m/z=310 (M+); anal. calcd. for
A solution of 2-indolylallylamide (1 mmol), PdCl2ACTHNUTRGNEN(UG MeCN)2
C18H15ClN2O: C 69.57, H 4.86, N 9.01; found: C 69.41, H
5.09, N 9.23.
2-Allyl-4-(chloromethyl)-2,3,4,9-tetrahydropyridoACTHNUTRGNEU[GN 3,4-
(0.05 mmol) and CuCl2 (3 mmol) in DMF (5 mL) was re-
fluxed for 3 h. After cooling, brine was added (10 mL) and
the solution was extracted with Et2O (3ꢃ20 mL). The or-
ganic phase was dried over Na2SO4, then the solvent was
evaporated under reduced pressure. The products were puri-
fied by flash chromatography.
b]indol-1-one (3d): Yield: 77%; eluent: hexane/AcOEt 7:3;
pale yellow solid; mp1718C (i-Pr2O). 1H NMR (400 MHz,
CDCl3): d=3.49–3.54 (m, 1H), 3.60 (t, J=10.8 Hz, 1H),
3.79 (dd, J=3.7, 10.8 Hz, 1H), 4.18 (dd, J=6.4, 15.0 Hz,
1H), 4.48 (dd, J=6.0, 15.0 Hz, 1H), 5.35 (d, J=10.8 Hz,
1H), 5.40 (dd, J=1.1, 17.1 Hz, 1H), 5.92–6.00 (m, 1H), 7.20
(dd, J=7.3, 8.0 Hz, 1H), 7.35 (dd, J=7.3, 8.3 Hz, 1H), 7.57
(d, J=8.3 Hz, 1H), 7.65 (d, J=8.0 Hz, 1H), 11.05 (br s,
1H); 13C NMR (100 MHz, CDCl3): d=35.5 (d), 44.5 (t), 49.3
(t), 113.6 (d), 117.9 (s), 119.1 (t), 120.1 (d), 121.0 (d), 124.9
(s), 125.4 (d), 127.5 (s), 133.2 (d), 138.3 (s), 161.1 (s); IR:
n=3455, 1668 cmÀ1; MS: m/z=274 (M+); anal. calcd. for
C15H15ClN2O: C 65.57, H 5.50, N 10.20; found: C 65.55, H
5.31, N 10.36.
(2-Methyl-1-oxo-2,3,4,9-tetrahydropyridoACTHUNRTGNEUNG[3,4-b]indol-4-
yl)methyl formate (4a): Yield: 87%; eluent: hexane/AcOEt
1:1; pale orange solid; mp 1298C (i-Pr2O). 1H NMR
(400 MHz, CDCl3): d=3.23 (s, 3H), 3.56–3.65 (m, 2H), 3.97
(dd, J=5.2, 10.1 Hz, 1H), 4.26 (t, J=10.1 Hz, 1H), 4.53 (dd,
J=4.7, 11.2 Hz, 1H), 7.18 (dd, J=7.3, 7.9 Hz, 1H), 7.34 (t,
J=7.3, 8.2 Hz, 1H), 7.58 (d, J=8.2 Hz, 1H), 7.67 (d, J=
7.9 Hz, 1H), 8.15 (s, 1H), 9.97 (br s, 1H); 13C NMR
(100 MHz, CDCl3): d=32.4 (d), 34.8 (q), 52.0 (t), 63.7 (t),
113.5 (d), 117.2 (s), 120.3 (d), 120.9 (d), 125.3 (d), 125.4 (s),
127.7 (s), 137.9 (s), 161.2 (s), 161.8 (s); IR: n=3421, 1658,
1730 cmÀ1; MS: m/z=258 (M+); anal. calcd. for C14H14N2O3:
C 65.11, H 5.46. N 10.85; found: C 65.24, H 5.21, N 11.04.
4-(Chloromethyl)-2-cyclopentyl-2,3,4,9-tetrahydropyrido-
ACHTUNGTRENNUNG[3,4-b]indol-1-one (3e): Yield: 88%; eluent: hexane/AcOEt
8:2; white solid; mp 2098C (i-Pr2O). 1H NMR (400 MHz,
CDCl3): d=1.70–2.07 (m, 8H), 3.45–3.55 (m, 2H), 3.74–3.90
(m, 2H), 3.91 (d, J=13.3 Hz, 1H), 5.31–5.35 (m, 1H), 7.19
(dd, J=7.5, 8.0 Hz, 1H), 7.35 (dd, J=7.5, 8.3 Hz, 1H), 7.55
(d, J=8.3 Hz, 1H), 7.64 (d, J=8.0 Hz, 1H), 11.08 (s br,
1H); 13C NMR (100 MHz, CDCl3): d=24.9 (t), 25.2 (t), 28.6
(t), 30.2 (t), 35.3 (d), 43.9 (t), 44.0 (t), 53.8 (d), 113.5 (d),
117.3 (s), 120.0 (d), 121.0 (d), 124.8 (s), 125.3 (d), 128.1 (s),
138.3 (s), 161.2 (s); IR: n=3439, 1671 cmÀ1; MS: m/z=302
(M+); anal. calcd. for C17H19ClN2O: C 67.43, H 6.32, N 9.25;
found: C 67.55, H 6.05, N 9.12.
(2-Cyclohexyl-1-oxo-2,3,4,9-tetrahydropyridoACTHNUTRGNE[NUG 3,4-b]indol-
4-yl)methyl formate (4b): Yield: 84%; eluent: hexane/
1
AcOEt 8:2; pale yellow solid; mp 1798C (i-Pr2O); H NMR
(400 MHz, CDCl3): d=1.17–1.92 (m, 10H), 3.52–3.56 (m,
1H), 3.69–3.79 (m, 2H), 4.11 (t, J=10.2 Hz, 1H), 4.51 (dd,
J=4.7, 11.1 Hz, 1H), 4.69–4.71 (m, 1H), 7.18 (dd, J=7.5,
7.8 Hz, 1H), 7.33 (dd, J=7.5, 8.2 Hz, 1H), 7.51 (d, J=
8.2 Hz, 1H), 7.67 (d, J=7.8 Hz, 1H), 8.16 (s, 1H), 10.30 (br
s, v); 13C NMR (100 MHz, CDCl3): d=26.0 (t), 26.2 (t), 30.1
(t), 30.5 (t), 31.0 (t), 32.0 (d), 43.8 (t), 51.9 (d), 63.1 (t),
113.1 (d), 116.3 (s), 120.4 (d), 121.0 (d), 125.1 (s), 125.2 (d),
128.4 (s), 138.0 (s), 160.6 (s), 161.1 (s); IR: n=3425, 1650,
1718 cmÀ1; MS: m/z=326 (M+); anal. calcd. for C19H22N2O3:
C 69.92, H 6.79, N 8.58; found: C 69.65, H 7.04, N 8.72.
4-(Bromomethyl)-2-methyl-2,3,4,9-tetrahydropyridoACTHNUTRGNEU[GN 3,4-
b]indol-1-one (5a): Yield: 78%; eluent: hexane/AcOEt 1:1;
white solid; mp 2028C (i-Pr2O). 1H NMR (400 MHz,
CDCl3): d=3.29 (s, 3H), 3.49–3.51 (m, 1H), 3.52–3.55 (m,
1H), 3.61–3.65 (m, 1H), 3.80–3.85 (m, 1H), 3.91–3.99 (m,
1H), 7.27 (dd, J=7.8, 7.0 Hz, 1H), 7.39 (dd, J=7.0, 8.2 Hz,
1H), 7.51 (d, J=8.2 Hz, 1H), 7.61 (d, J=7.8 Hz, 1H), 10.5
(s br, 1H); 13C NMR (100 MHz, CDCl3): d=32.7 (t), 34.6
(q), 35.1 (d), 52.9 (t), 113.3 (d), 119.2 (s), 119.7 (d), 121.1
(d), 124.1 (s), 125.1 (s), 125.8 (d), 126.7 (s), 161.0 (s); IR:
n=3437, 1660 cmÀ1; MS: m/z=293 (M+); anal. calcd. for
C13H13BrN2O: C 53.26, H 4.47, N 9.56; found: C 53.44, H
4.65, N 9.77.
(2-Phenyl-1-oxo-2,3,4,9-tetrahydropyridoACTHUNRTGNEUNG[3,4-b]indol-4-
yl)methyl formate (4c): Yield: 73%; eluent: hexane/AcOEt
65:35; pale yellow solid; mp 1438C (i-Pr2O). 1H NMR
(400 MHz, CDCl3): d=3.66–3.71 (m, 1H), 4.07 (dd, J=2.6,
12.7 Hz, 1H), 4.34–4.44 (m, 2H), 4.65 (dd, J=4.8, 11.2 Hz,
1H), 7.20 (dd, J=7.5, 7.8 Hz, 1H), 7.28–7.40 (m, 5H), 7.46–
7.54 (m, 2H), 7.71 (d, J=8.0 Hz, 1H), 8.12 (s, 1H), 10.93 (br
s, 1 H); 13C NMR (100 MHz, CDCl3): d=32.8 (d), 53.4 (t),
63.5 (t), 113.5 (d), 117.8 (s), 120.5, (d), 121.1 (d), 125.1 (s),
125.7 (d), 126.2 (d), 127.1 (d), 127.8 (s), 129.5 (d), 138.5 (s),
142.6 (s), 161.0 (s), 161.1 (s); IR: n=3441, 1682, 1710 cmÀ1
;
4-(Bromomethyl)-2-cyclohexyl-2,3,4,9-tetrahydropyrido-
G
MS: m/z=320 (M+); anal. calcd. for C19H16N2O3: C 71.24, H
5.03, N 8.74; found: C 71.27, H 4.85, N 8.59.
Adv. Synth. Catal. 2012, 354, 159 – 170
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
165